The global pet cancer therapeutics Market is projected worth US$345.2 million by 2026 and the market is projected to showcase 10.6% CAGR during the forecast period. The pet cancer therapeutics market is driven by the rapid adoption of innovative pet care medicines.
The growing trend of pet adoption such as dogs and cats owing to theenhanced economic status of people will drive the global market. Furthermore, the rising prevalence of pet cancer and growing pet healthcare expenditure will stimulate the growth of the global pet cancer therapeutics market. Growing research and development initiatives by manufacturers to treat pet cancer will result in the launch of novel products in the market over the forecast years. The key players with a strong product portfolio are expected to expand the market share with their innovative treatments. The contrary effects of pet cancer drugs and lack of awareness about pet diseases among the pet owners will restrain market growth. The cost of pet cancer therapeutics will further hamper the pet health in most developing countries across the globe.
The mast cell cancer sub-segment is expected to hold the largest share of the global pet cancer therapeutics market. Also, the availability of various drugs for cancer treatment. But, the shifting trend from the mast cell cancer to other cancer treatments is expected to grow at a moderate pace during the forecast period.The dog cancer therapeutics market in the species segment held the largest revenue in the global market in the upcoming years.The rise in the existence of the high number of marketed drugs and vaccines for cancer treatment in dogs will boost the overall market growth.
The global pet cancer therapeutics market is segmented into medicine type, species, cancer type, and region. On the basis of medicine type, the global pet cancer therapeutics market is segmented into vaccines and chemotherapy drugs. On the basis of species, the global pet cancer therapeutics market is segmented into dogs and cats. On the basis of cancer type, the global pet cancer therapeutics market is segmented into melanoma, mammary, squamous cell cancer, mast cell cancer, mammary, and lymphoma. On the basis of the region, the global pet cancer therapeutics market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Based on the type, the global pet cancer therapeutics market can majorly be segmented into three sub-segments, which are water-based, solvent-based, and UV-cured. The UV-cured sub-segment is expected to dominate the global pet cancer therapeutics market as these inks usually produce less volatile organic compounds and hazardous air pollutants.Also, the commercial printing segment is anticipated to expand at a significant pace due to the increase in the preference of pet cancer therapeutics in commercial printing such as architectural designs, textiles, fine arts, desktop publishing, advertising, and other applications.
The North America region is expected to dominate the global pet cancer therapeutics market owing to the huge presence of key players in the U.S and the existence of various pet cancer medicines and rise in healthcare spending on pets.Also, the North America region is expected to grow at a moderate pace owing to the rise in consumption for mast cell cancer applications.These factors expected to drive the pet cancer therapeutics market in the North America region.
The major players associated with the pet cancer therapeutics market are Aratana Therapeutics, Vetivax, Regeneus, Zoetis, AB Science, Merial, and VetDC, etc. There is a moderate level of competition seen among the manufacturers as they have targeted different pet cancers with their unique product offering.Moreover, the key players in the global pet cancer therapeutics market are also focusing mainly on forming strategic partnerships with other established players in order to expand their business geographically in order to gain significant market share.
Market By Medicine Type
Market By Species
Market By Cancer Type
Market By Geography
Introduction According to Acumen Research and Consulting, the global Behavioral Health market is forecasted to grow at striking CAGR around 2.5 % over the forecast time frame and reach around US$ 240 billion by 2026. Behavioural health involves non-pharmacological therapies for circumstances like mental health, drug abuse disorder, etc. Due to mental illnesses,
The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026. Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimu
The global sacral nerve stimulation market size is expected to reach over 2.3 USD billion by 2026 at the CAGR 12.1% during the forecast period, 2019-2026. A Sacral nerve stimulation is implanted as a device to control bladder functions by delivering controlled electrical impulses to the sacral nerves that modulate the neural pathways. It is an effective and safe treatment for patients suffering fro
The global market for Medical Imaging Workstations is estimated to grow at a significant rate of 8.5% during the forecasted period and is expected to reach over 2.3 billion by 2026. Medical imaging workstations are used in the hospitals while setting up the equipments. During last few years there is an significant increase in the prevalence of the various diseases and accidents which has increased
The global laser hair removal market value is accounted over USD 3.9 Billion by 2026 and is expected to grow at CAGR 15.4% during the forecast period 2019-2026. The global laser hair removal product market is driven by increased awareness regarding personal appearance and rising health awareness among the population. Additionally, improved standard of living and rising disposable income tremendously affects the laser hair remo
The global Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach over 4.2 USD billion by 2026 and growing at CAGR 11.6% during the forecast period 2019-2026. During last few years, there is a significant increase in the number of respiratory related diseases. Increasing prevalence of the various respiratory diseases, rising geriatric population across the globe, and increasing awareness about health have driven t